Kukje Pharma Co., Ltd. (KRX:002720)
South Korea · Delayed Price · Currency is KRW 3,430.00
+85.00 (2.54%)
Nov 2, 2026, 3:30 PM KST
Kukje Pharma Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 181,267 | 175,496 | 156,463 | 135,373 | 126,583 | 119,746 |
Revenue Growth | 8.02% | 12.16% | 15.58% | 6.94% | 5.71% | -8.17% |
Gross Profit Gross Profit Growth | 97,255 | 93,645 | 82,495 | 67,225 | 63,254 | 54,470 |
Operating Income Operating Income Growth | 4,475 | 6,185 | 6,702 | -1,989 | 5,273 | -1,676 |
Net Income Net Income Growth | 5,001 | 5,698 | 5,205 | -8,415 | 3,557 | -1,559 |
Earnings Per Share EPS Growth | 240.38 | 279.51 | 255.64 | -415.49 | 175.58 | -77.14 |
EPS Growth | -23.34% | 9.34% | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceuticals Pharmaceuticals Growth | 178,386 | 170,204 | 149,768 | 130,436 | 120,570 | 112,485 |
Non-Pharmaceutical Non-Pharmaceutical Growth | 345.82 | 338.65 | 416.98 | 837.86 | 3,028 | 3,259 |
Other Other Growth | 2,535 | 4,954 | 6,278 | 4,099 | 2,992 | 4,018 |
Total Total Growth | 181,267 | 175,496 | 156,463 | 135,373 | 126,583 | 119,746 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 15,722 | 10,724 | 8,755 | 10,632 | 5,559 | 7,903 |
Total Debt Total Debt Growth | 31,387 | 30,404 | 29,512 | 30,662 | 28,596 | 35,987 |
Net Cash (Debt) Net Cash Growth | -15,665 | -19,680 | -20,757 | -20,030 | -23,037 | -28,084 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -753.75 | -965.47 | -1019.42 | -988.96 | -1137.06 | -1385.71 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 6,691 | 5,835 | 3,940 | 3,575 | 6,504 | 9,597 |
Capital Expenditures CapEx Growth | -4,366 | -3,619 | -2,911 | -1,046 | -1,259 | -1,892 |
Free Cash Flow Free Cash Flow Growth | 2,325 | 2,216 | 1,029 | 2,529 | 5,245 | 7,705 |
Free Cash Flow Growth | -64.67% | 115.42% | -59.32% | -51.78% | -31.93% | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 53.65% | 53.36% | 52.73% | 49.66% | 49.97% | 45.49% |
Operating Margin | 2.47% | 3.52% | 4.28% | -1.47% | 4.17% | -1.40% |
Pretax Margin | 3.13% | 3.67% | 4.22% | -4.93% | 3.75% | -0.93% |
Profit Margin | 2.76% | 3.25% | 3.33% | -6.22% | 2.81% | -1.30% |
FCF Margin | 1.28% | 1.26% | 0.66% | 1.87% | 4.14% | 6.43% |
Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 30.000 | 30.000 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 0.87% | 0.73% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.27 | 15.37 | 19.80 | - | 29.83 | - |
P/FCF Ratio | 31.22 | 39.51 | 100.14 | 47.40 | 20.23 | 14.65 |
PS Ratio | 0.40 | 0.50 | 0.66 | 0.89 | 0.84 | 0.94 |